News


1 - 12 of 68 items

Needle-free diabetes monitoring

Needle-free diabetes monitoring

Monday, 24 de January de 2022

Continuous glucose monitoring is the gold standard approach for diabetes management. An under-the-skin sensor is expected to make finger pricking and visible patches a thing of the past.

2022 EU4Health work programme adopted to invest over 835 million in health

2022 EU4Health work programme adopted to invest over 835 million in health

Monday, 17 de January de 2022

In 2022, the EU4Health will continue to invest in building stronger, more resilient health systems and pave the way for the European Health Union. With a budget of over €835 million, the new work programme will provide an unparalleled level of EU investment in health and ensure ambitious and decisive action in four focus areas: crisis preparedness, disease prevention, health systems and healthcare workforce, and digitalisation.

47 million fund to protect intellectual property of EU SMEs in their COVID-19 recovery and green and digital transitions

47 million fund to protect intellectual property of EU SMEs in their COVID-19 recovery and green and digital transitions

Tuesday, 11 de January de 2022

The Commission and the European Union Intellectual Property Office (EUIPO) launched the new EU SME Fund, which offers vouchers for EU-based SMEs to help them protect their intellectual property (IP) rights. This is the second EU SME Fund aiming at supporting SMEs in the COVID-19 recovery and green and digital transitions for the next three years (2022-2024).

These are the proteins causing strokes and heart attacks in COVID-19 patients

These are the proteins causing strokes and heart attacks in COVID-19 patients

Tuesday, 11 de January de 2022

When the coronavirus enters the body, it starts producing 29 proteins. Then a new virus is formed, and that virus produces 29 new proteins, and so on. It has been 2 years since the global pandemic started, and we still do not know which of the proteins in the SARS-CoV-2 virus are responsible for cases of severe vascular disease that negatively impacts our arteries and veins.

Fast migraine relief through an oral adhesive

Fast migraine relief through an oral adhesive

Monday, 20 de December de 2021

Migraine can have a debilitating impact on sufferers. Migraine is a neurological condition with multiple recurring symptoms including nausea, throbbing headache and sensitivity to light. It severely disrupts the everyday life of sufferers, who are forced to take days off work and be less productive. Thanks to a European project, a drug-delivery film for fast eradication will soon be on the market.

European Health Emergency preparedness and Response Authority (HERA): Getting ready for future health emergencies

European Health Emergency preparedness and Response Authority (HERA): Getting ready for future health emergencies

Thursday, 16 de December de 2021

The European Commission is launching the European Health Emergency preparedness and Response Authority (HERA) to prevent, detect, and rapidly respond to health emergencies. HERA will anticipate threats and potential health crises, through intelligence gathering and building the necessary response capacities. When an emergency hits, HERA will ensure the development, production and distribution of medicines, vaccines and other medical countermeasures – such as gloves and masks – that were often lacking during the first phase of the coronavirus response. 

EU replaces COVID-19 vaccines export authorisation mechanism with new monitoring tool

EU replaces COVID-19 vaccines export authorisation mechanism with new monitoring tool

Monday, 29 de November de 2021

The EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021. This means that, as of 1 January 2022, vaccine producers will no longer have to request an authorisation for the export of vaccines outside the EU. Transparency of exports will continue to be ensured through a new monitoring mechanism that will provide the European Commission with timely, company-specific vaccine export data. The Commission will continue to monitor the ongoing epidemiological situation in order to take appropriate measures if necessary.

Commission welcomes approval of the Pact for Research and Innovation in Europe and future governance of the European Research Area

Commission welcomes approval of the Pact for Research and Innovation in Europe and future governance of the European Research Area

Monday, 29 de November de 2021

The Pact for R&I defines common values and principles for research and innovation in Europe, such as freedom of scientific research and free circulation of researchers and knowledge. It also outlines 16 shared priority areas for joint action, ranging from fostering open science for faster sharing of knowledge and data, to reinforcing the scientific leadership and excellence of the European Union, with the involvement of all European regions and citizens.

EMA evaluating data on booster dose of COVID-19 Vaccine Janssen

EMA evaluating data on booster dose of COVID-19 Vaccine Janssen

Monday, 22 de November de 2021

EMA’s human medicines committee (CHMP) will carry out an accelerated assessment of data submitted by the company that markets the vaccine. These data include results from more than 14,000 adults who received a second dose of COVID-19 Vaccine Janssen or placebo (a dummy treatment) two months after the initial dose. 

Accurate but non-invasive test for breast cancer in a kit

Accurate but non-invasive test for breast cancer in a kit

Friday, 19 de November de 2021

Early diagnosis is a must for breast cancer; a late diagnosis may mean more invasive treatment or, at worst, a low survival rate. The project BrEXo-Apt, partly funded by the EU, has developed a non-invasive yet accurate test for breast cancer that is to be available in a kit form. Based on specific biomarkers in the blood, the screening enables early tumour detection on the largest scale of patients possible.